Skip to main content

Research publications repository

    • čeština
    • English
  • English 
    • čeština
    • English
  • Login
View Item 
  •   CU Research Publications Repository
  • Fakulty
  • Faculty of Science
  • View Item
  • CU Research Publications Repository
  • Fakulty
  • Faculty of Science
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The Role of IL-6 in Cancer Cell Invasiveness and Metastasis — Overview and Therapeutic Opportunities

summarizing article
Creative Commons License IconCreative Commons BY Icon
published version
  • no other version
Thumbnail
File can be accessed.Get publication
Author
Rašková, Magdalena
Lacina, LukášORCiD Profile - 0000-0002-1750-9933WoS Profile - V-6575-2019Scopus Profile - 12764651100
Kejík, ZdeněkORCiD Profile - 0000-0002-2215-4890WoS Profile - AAT-7263-2020
Venhauerová, Anna
Skaličková, MarkétaORCiD Profile - 0009-0002-8691-805X
Kolář, Michal
Jakubek, MilanORCiD Profile - 0000-0001-7323-3903WoS Profile - ABC-3339-2021Scopus Profile - 40561454600
Rösel, DanielORCiD Profile - 0000-0001-7221-8672WoS Profile - J-7507-2017Scopus Profile - 6505670485
Smetana, KarelORCiD Profile - 0000-0002-7878-8403WoS Profile - D-7039-2017Scopus Profile - 55666847000
Brábek, JanORCiD Profile - 0000-0001-7754-7299WoS Profile - J-9836-2017Scopus Profile - 6505767640

Show other authors

Publication date
2022
Published in
Cells
Volume / Issue
11 (22)
ISBN / ISSN
ISSN: 2073-4409
ISBN / ISSN
eISSN: 2073-4409
Metadata
Show full item record
Collections
  • 1. Faculty of Medicine
  • Faculty of Science

This publication has a published version with DOI 10.3390/cells11223698

Abstract
Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various homeostatic and pathological processes. These activities range from regulating embryonic development, wound healing and ageing, inflammation, and immunity, including COVID-19. In this review, we summarise the role of IL-6 signalling pathways in cancer biology, with particular emphasis on cancer cell invasiveness and metastasis formation. Targeting principal components of IL-6 signalling (e.g., IL-6Rs, gp130, STAT3, NF-κB) is an intensively studied approach in preclinical cancer research. It is of significant translational potential; numerous studies strongly imply the remarkable potential of IL-6 signalling inhibitors, especially in metastasis suppression.
Keywords
IL-6, cancer, metastasis
Permanent link
https://hdl.handle.net/20.500.14178/1804
Show publication in other systems
WOS:000887160100001
SCOPUS:2-s2.0-85142425788
PUBMED:36429126
License

Full text of this result is licensed under: Creative Commons Uveďte původ 4.0 International

Show license terms

xmlui.dri2xhtml.METS-1.0.item-publication-version-

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

About Repository

About This RepositoryResearch outputs typologyRequired metadataDisclaimerCC Linceses

Browse

All of DSpaceCommunities & CollectionsWorkplacesBy Issue DateAuthorsTitlesSubjectsThis CollectionWorkplacesBy Issue DateAuthorsTitlesSubjects

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV